Biotium, a supplier of cutting-edge life science reagents, has acquired Cell Data Sciences RNAstorm and DNAstorm kits for RNA/DNA extraction. Biotium, which previously distributed the Cell Data Sciences kits, will now be their sole manufacturer. The extraction kits will be offered from the Biotium website and authorized distributors.
Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC).
Thermo Fisher Scientific and Inpeco have agreed to develop connectivity between the Thermo Scientific Cascadion SM Clinical Analyzer and the Inpeco FlexLab laboratory automation system (LAS). This interface will enable primary tubes on the Inpeco LAS to be transported to the Cascadion analyzer for automated loading, pre-treatment, and analysis.
“This development, using the market leading automation and software provided by Inpeco, will further enhance the capability of the Cascadion analyzer in managing samples in a fully automated manner. It will increase and enhance the analytical scope for laboratories using an LAS supported by Inpeco and add additional productivity benefits for Cascadion users,” said Heikki Immonen, director of product lifecycle and marketing, Thermo Scientific.
The Cascadion SM Clinical Analyzer is currently commercially available in the US and Europe, with continued expansion into new geographies. After the initial launch of Cascadion SM 25-OH Vitamin D assay, the CE-IVD marked Cascadion SM Immunosuppressants Panel was launched in Europe in 2020.
“The development of the interface to the Inpeco LAS system will make this a first to market tracked solution for LC-MS/MS technology,” said Francesco Parodi, total lab automation product manager, Inpeco S.A. “We are excited at the prospect of having Cascadion link to our system and extend our range of analyzer connectivity to include LC-MS/MS technology.”
Bacterial identification can take hours and often longer, precious time when diagnosing infections and selecting appropriate treatments. There may be a quicker, more accurate process according to researchers at KAIST (Korea Advanced Institute of Science and Technology). By teaching a deep learning algorithm to identify the “fingerprint” spectra of the molecular components of various bacteria, […]
More than three times as many people may have died worldwide as a result of the pandemic than official COVID-19 death records suggest, according to an analysis published in The Lancet.
Three Finnish life science experts – Abacus Diagnostica, a frontrunner in molecular testing and rapid PCR test systems, Kaivogen, a specialist in immunoassays and antibody tests, and Labrox, an innovator of high technology laboratory instruments and diagnostic readers – have joined forces to form a global diagnostics pioneer. The name of the new company is […]
Selux Diagnostics, which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform.
Orbit Discovery, a ground-breaking peptide discovery company, and WuXi AppTec, a leading provider of R&D and manufacturing services for the pharmaceutical and healthcare industries, have formed a partnership wherein Orbit will combine its leading peptide discovery platform and experience with WuXi AppTec’s down-stream capabilities.
MolGen showcased its high-tech laboratory automation technology, customized diagnostic workflow and its latest products and services to technology professionals and life science researchers at SLAS 2022 in Boston, US, in February. MolGen displayed its complete diagnostics workflow and molecular automation product offerings for human diagnostics and pharmaceutical sciences that are available worldwide.
ProBioGen has inked a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology.